Back to Search Start Over

E2F1 interacts with BCL-xL and regulates its subcellular localization dynamics to trigger cell death.

Authors :
Vuillier C
Lohard S
Fétiveau A
Allègre J
Kayaci C
King LE
Braun F
Barillé-Nion S
Gautier F
Dubrez L
Gilmore AP
Juin PP
Maillet L
Source :
EMBO reports [EMBO Rep] 2018 Feb; Vol. 19 (2), pp. 234-243. Date of Electronic Publication: 2017 Dec 12.
Publication Year :
2018

Abstract

E2F1 is the main pro-apoptotic effector of the pRB-regulated tumor suppressor pathway by promoting the transcription of various pro-apoptotic proteins. We report here that E2F1 partly localizes to mitochondria, where it favors mitochondrial outer membrane permeabilization. E2F1 interacts with BCL-xL independently from its BH3 binding interface and induces a stabilization of BCL-xL at mitochondrial membranes. This prevents efficient control of BCL-xL over its binding partners, in particular over BAK resulting in the induction of cell death. We thus identify a new, non-BH3-binding regulator of BCL-xL localization dynamics that influences its anti-apoptotic activity.<br /> (© 2017 The Authors.)

Details

Language :
English
ISSN :
1469-3178
Volume :
19
Issue :
2
Database :
MEDLINE
Journal :
EMBO reports
Publication Type :
Academic Journal
Accession number :
29233828
Full Text :
https://doi.org/10.15252/embr.201744046